Back
Aytu BioPharma Quote, Financials, Valuation and Earnings
Sponsored
AYTU
Sponsored
Forget Bitcoin - This Is the Real Opportunity of 2024
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
40
AYTU
Aytu BioPharma
Last Price:
2.35
Seasonality Move:
78.97%
7 Day Trial
ALL ACCESS PASS
$
7
Why Over 21,997 Investors Are Flocking to This Opportunity
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.Aytu BioPharma Price Quote
$2.35
-0.01 (-17.51%)
(Updated: September 28, 2024 at 6:20 AM ET)
Aytu BioPharma Key Stats
Sell
40
Aytu BioPharma (AYTU)
is a Sell
Day range:
$2.30 - $2.60
52-week range:
$2.20 - $3.50
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.16
P/B ratio:
0.51%
Volume:
237.4K
Avg. volume:
24.9K
1-year change:
22.92%
Market cap:
$14.1M
Revenue:
$81M
EPS:
$-2.86
How Much Does Aytu BioPharma Make?
-
How Much Are Aytu BioPharma's Sales Annually?
AYTU Revenues are $81M -
How Much Profit Does Aytu BioPharma's Make A Year?
AYTU net income is -$15.8M
Is Aytu BioPharma Growing As A Company?
-
What Is Aytu BioPharma's Growth Rate Quarterly?
Quarterly YoY revenue growth is -0.42% -
What Is Aytu BioPharma's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
Aytu BioPharma Stock Price Performance
-
Did Aytu BioPharma Stock Go Up Last Month?
Aytu BioPharma share price went up by 0% last month -
Did AYTU's Share Price Rise Over The Last Year?
AYTU share price rose by 22.92% over the past 1 year
What Is Aytu BioPharma 52-Week High & Low?
-
What Is Aytu BioPharma’s 52-Week High Share Price?
Aytu BioPharma has traded as high as $3.50 over the past 52 weeks -
What Is Aytu BioPharma’s 52-Week Low Share Price?
Aytu BioPharma has traded as low as $2.20 over the past 52 weeks
Aytu BioPharma Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Aytu BioPharma?
-
How Much Debt Does Aytu BioPharma Have?
Total long term debt quarterly is $15.1M -
How Much Cash Does Aytu BioPharma Have?
Cash and short term investments quarterly total is $20M -
What Is Aytu BioPharma’s Book Value Per Share?
Book value per share is 4.64
Is Aytu BioPharma Cash Flow Positive?
-
What Is AYTU Cash Flow From Operations?
Cash flow from operations (TTM) is -$1.4M -
What Is Aytu BioPharma’s Cash Flow From Financing?
Cash flow from financing (TTM) is -$1.3M -
What Is Aytu BioPharma’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$329K
Aytu BioPharma Return On Invested Capital
-
Is Management Doing A Good Job?
AYTU return on invested capital is -32.57% -
What Is Aytu BioPharma Return On Assets?
ROA measures how assets are converting to revenues and is -12.23% -
What Is AYTU Return On Equity?
ROE is a measure of profitability and is -48.64%
Aytu BioPharma Earnings Date & Stock Price
-
What Is Aytu BioPharma's Stock Price Today?
A single share of AYTU can be purchased today for 2.36 -
What Is Aytu BioPharma’s Stock Symbol?
Aytu BioPharma trades on the nasdaq under the ticker symbol: AYTU -
When Is Aytu BioPharma’s Next Earnings Date?
The next quarterly earnings date for Aytu BioPharma is scheduled on November 29, 2024 -
When Is AYTU's next ex-dividend date?
Aytu BioPharma's next ex-dividend date is September 28, 2024 -
How To Buy Aytu BioPharma Stock?
You can buy Aytu BioPharma shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Aytu BioPharma Competitors
-
Who Are Aytu BioPharma's Competitors?
Below is a list of companies who compete with Aytu BioPharma or are related in some way:
Aytu BioPharma Dividend Yield
-
What Is AYTU Dividend Yield?
Aytu BioPharma’s dividend yield currently is 0% -
What Is Aytu BioPharma’s Payout Ratio?
Aytu BioPharma’s payout ratio is 0% -
When Did Aytu BioPharma Last Pay A Dividend?
The latest dividend pay date is September 28, 2024 -
What Is Aytu BioPharma’s Dividend Per Share?
Aytu BioPharma pays a dividend of $0.00 per share
Aytu BioPharma Analyst Estimates
YoY Growth | Past Surprise | |
---|---|---|
EPS: | 0% | 0% |
Revenue: | -41.51% | -1.78% |
Analyst Recommendations
Buy Recommendations: | 0 |
---|---|
Hold Recommendations: | 0 |
Sell Recommendations: | 0 |
Price Target: | 8.00 |
Upside from Last Price: | 238.98% |